Article
Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice.
Cancer research - 15 Feb 2001
Hemmeryckx B, van Wijk A, Reichert A, Kaartinen V, de Jong R, Pattengale P K, Gonzalez-Gomez I, Groffen J, Heisterkamp N
Abstract excerpt
The adapter protein Crkl has been implicated in the abnormal signal transduction pathways activated by the Bcr/Abl oncoprotein, which causes Philadelphia-positive leukemias in humans. To investigate the role of Crkl in tumorigenesis, we have generated transgenic mice that express human Crkl from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
